Loading
Life sciences · Journal article
Journal of Clinical Medicine · September 28, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Journal article.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
Background/Objectives: Breast cancer management relies on multidisciplinary team (MDT) decisions that integrate clinical, radiological, pathological, and patient-related factors. Large language models (LLMs) may support such decisions, but evidence based on real-world cases remains limited. Methods: We evaluated the agreement between ChatGPT-5.5 (OpenAI, San Francisco, CA, USA) and real MDT management of patients with invasive breast cancer. In this single-center, retrospective, proof-of-concept study, standardized preoperative clinical vignettes for 86 patients with invasive breast carcinoma were independently evaluated by GPT-5.5 (frozen prompt, Medium reasoning mode, Web Search enabled). AI-generated recommendations were compared with the MDT reference standard across eight therapeutic domains (four surgical, four non-surgical), yielding 688 individual decisions. Agreement was summarized descriptively and with Cohen’s κ. Results: GPT-5.5 produced complete recommendations for all vignettes. Overall concordance was 90.8% (625/688). Agreement was highest for endocrine therapy, radiotherapy, and targeted therapy (100% each) and for axillary surgery (93.0%, κ = 0.86), and lowest for breast reconstruction (80.2%), oncoplastic surgery (82.6%) and neoadjuvant chemotherapy (83.7%). Surgical concordance was 85.8% (295/344). Discordances occurred predominantly in individualized surgical decisions; none were observed for endocrine therapy, radiotherapy, or targeted therapy. Conclusions: GPT-5.5 showed high overall concordance with real MDT decisions, particularly for guideline-driven systemic therapy, but was less reliable for individualized surgical planning. These findings should be regarded as exploratory and cannot be assumed to be generalizable across institutions or clinical settings. LLMs should complement, not replace, multidisciplinary expertise; prospective multicenter validation is warranted.